[IMG]file:///tmp/moz-screenshot.png[/IMG]    	 	 	 	 	body, div, table, thead, tbody, tfoot, tr, th, td, p { font-family: "Liberation Sans"; font-size: x-small; } 	   	 	 		 			Drug: KRP-104 QD Drug: Placebo Drug: Metformin|Drug: Placebo Drug: Metformin|Drug: KRP-104 BID Drug: Placebo Drug: Metformin    Phase 2
Drug: Dapagliflozin    Phase 1
Drug: MK-3102|Drug: Matching placebo to MK-3102|Drug: Basal medication    Phase 3
Dietary Supplement: Vitamin C|Drug: glyburide    Phase 1
Drug: Insulin glargine new formulation (HOE901)|Drug: Insulin glargine (HOE901)    Phase 3
Drug: Pioglitazone|Drug: Placebo|Drug: Pioglitazone|Drug: Placebo    Phase 4
Drug: Metformin HCl and Colesevelam Placebo|Drug: Metformin HCl tablets and Colesevelam tablets|Drug: Colesevelam placebo|Drug: Colesevelam    Phase 3
Drug: Insulin-Levemir|Drug: Exenatide-Bayetta|Drug: Insulin-Levemir and Exenatide-Bayetta|Device: SenseWear Pro3® armband|Device: DexCom CGM    Phase 4
Drug: exenatide once weekly|Drug: metformin|Drug: sitagliptin|Drug: pioglitazone    Phase 3
Drug: intensive insulin group|Drug: Oral AntiDiabetic Drug (glimepiride and metformin)    Phase 4
Drug: LY2189265|Drug: Sulfonylureas (SU)|Drug: Biguanides|Drug: Thiazolidinedione (TZD)|Drug: alpha-glucosidase inhibitor (a-GI)|Drug: Glinides    Phase 3
Drug: Insulin glargine new formulation (HOE901)|Drug: Insulin glargine (HOE901)    Phase 3
Drug: placebo|Drug: exenatide|Drug: exenatide    Phase 3
Drug: Vildagliptin (LAF237)|Drug: Voglibose|Drug: Vildagliptin and Voglibose    Phase 4
Drug: pioglitazone|Drug: insulin glargine    Phase 4
Drug: GSK189075 oral tablets|Drug: metformin tablets    Phase 1
Drug: Vildagliptin|Drug: Metformin|Drug: Vildagliptin + Metformin    Phase 3
Drug: Insulin glargine plus insulin analogues    Phase 4
Drug: Glipizide|Drug: Metformin    Phase 4
Drug: vildagliptin|Drug: Metformin Comparator    Phase 3
Drug: Dapagliflozin|Drug: Placebo matching Dapagliflozin    Phase 3
Drug: vildagliptin|Drug: Gliclazide    Phase 3
Drug: GSK1614235|Drug: Sitagliptin|Other: Placebo    Phase 1
Drug: Pioglitazone (Actos)|Drug: Anti-diabetic agent other than pioglitazone or rosiglitazone    Phase 1
Drug: Vildagliptin 100 mg qd|Drug: Metformin 1500 mg daily    Phase 3
Drug: Alogliptin and glimepiride|Drug: Alogliptin and glimepiride|Drug: Alogliptin and metformin|Drug: Alogliptin and metformin    Phase 2|Phase 3

KRP-104 QD  Phase 2
Placebo         Phase 2
Metformin     Phase 2
Placebo         Phase 2
Metformin      Phase 2
KRP-104 BID    Phase 2
 Placebo            Phase 2
Metformin    Phase 2